Related Experiment Videos
[Restrictive cardiomyopathies]
C Rapezzi1, P Ortolani, A M Traini
1Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi, Bologna.
Insights
Restrictive cardiomyopathies, including endomyocardial fibrosis and Loeffler endocarditis, are rare. Idiopathic restrictive cardiomyopathy is now the most frequent type in Western countries, necessitating a classification revision.
Area of Science:
- Cardiology
- Pathophysiology
- Medical Classification
Context:
- Restrictive cardiomyopathies are the least common of the three major categories of cardiomyopathic disorders in Western countries.
- The WHO/ISFC Task Force defines restrictive cardiomyopathy to include only endomyocardial fibrosis and Loeffler endocarditis.
- Many myocardial diseases can exhibit a restrictive pathophysiologic profile.
Purpose:
- To review recent advances in understanding restrictive cardiomyopathies.
- To highlight the identification of a common pathophysiology linking Loeffler endocarditis and endomyocardial fibrosis.
- To discuss the emergence and definition of idiopathic restrictive cardiomyopathy.
Summary:
- Recent research has identified a shared pathophysiology between Loeffler endocarditis and endomyocardial fibrosis.
- Idiopathic restrictive cardiomyopathy, characterized by restrictive physiology of unknown etiology and no infiltrative/storage disease evidence, is increasingly recognized.
- This condition is now the most frequent type of restrictive cardiomyopathy in Western populations.
Impact:
- The findings necessitate a revision of the current classification of cardiomyopathies, particularly restrictive myocardial disease.
- Improved understanding may lead to more accurate diagnosis and tailored treatment strategies for restrictive cardiomyopathies.
- This work emphasizes the need for updated diagnostic criteria and further etiological research into idiopathic restrictive cardiomyopathy.
Abstract:
The restrictive cardiomyopathies are the least common of the 3 major categories of cardiomyopathic disorders seen in Western countries. According to the report of the WHO/ISFC Task Force the term restrictive cardiomyopathy applies to only 2 conditions: endomyocardial fibrosis and Loeffler endocarditis while many specific myocardial diseases can develop a restrictive pathophysiologic profile along their natural history. During the last decade this topic has received 2 main contributions: the identification of a common pathophysiologic ground linking Loeffler endocarditis and endomyocardial fibrosis and the identification of the so-called idiopathic restrictive cardiomyopathy. This condition, defined as a myocardial disease with restrictive physiology, unknown etiology and without histological evidence of infiltrative or storage diseases, appears to be the single most frequent type of restrictive cardiomyopathy in Western countries. A revision of the current classification of cardiomyopathies and particularly of restrictive myocardial disease is necessary.